Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- With the recent announcement from the Drug Enforcement Administration (DEA) and the HHS that they will be extending the pandemic-era telehealth prescribing flexibilities for controlled substances through 2024, businesses and healthcare practitioners alike are facing an ever-evolving regulatory landscape. As these rules continue to adapt to the current climate, the question on every entrepreneur and manager's mind is, "How can we ensure compliance?" Enter the "Controlled Substances Handbook " available on ResearchAndMarkets.com - the essential guide for businesses navigating these changes.
The Controlled Substances Handbook is not just another cumbersome regulatory document. It's been crafted in easy-to-understand text, designed specifically to clarify the myriad of regulations under the Controlled Substances Act. With the DEA and HHS's decision to prolong the relaxed prescribing rules, businesses, particularly those in healthcare, are now tasked with understanding and adapting to these regulations. The Handbook offers a comprehensive solution.
Key Features and Benefits:
- Comprehensive Guidance: Whether you're in the realm of manufacturing, storing, shipping, distributing, importing, exporting, or disposing of controlled substances, the Handbook breaks down what's required of you.
- Simplified Language: Forget the legal jargon that’s difficult to decipher. This Handbook is written in plain English, making it accessible to entrepreneurs and managers, even if they aren't legal experts.
- Updated Requirements: With the extension of telehealth prescribing and the emergence of online pharmacies, the Handbook addresses the evolving requirements for electronic prescribing and the new standards of online pharmacy operations.
- Ensured Compliance: The Handbook keeps businesses ahead of the curve by providing them with the detailed DEA requirements. No more second-guessing if your operations are compliant; with this guide, you're always in the know.
The DEA and the HHS’s decision marks a shift towards a more digital-friendly healthcare system, with their recent statement highlighting the need for “a smooth transition for patients and practitioners” and time for “providers to come into compliance with any new standards or safeguards.” As they work towards new regulations by the fall of 2024, business entrepreneurs and managers need not wait in apprehension. With the “Controlled Substances Handbook”, they are equipped with a tool that's relevant, timely, and, above all, essential.
In today's world, where telemedicine is rapidly becoming the norm, understanding the nuances of controlled medication prescriptions has never been more crucial. The Controlled Substances Handbook ensures that businesses don't just survive these changes but thrive, armed with the knowledge to move forward with confidence.
For those looking to gain clarity and ensure their business operations are in compliance with the DEA's standards, the “Controlled Substances Handbook” is the quintessential guide to have by your side.
For more information about this directory visit https://www.researchandmarkets.com/r/agxdkr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
